drugset / Trial / NCT03957564
Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
To explore the clinical value of dynamic detection of circulating tumor cells(CTCs), circulating tumor DNA(ctDNA) and cell-free DNA(cfDNA) in neoadjuvant chemotherapy and operation of resectable or locally advanced gastric or gastro-oesophageal junction cancer.
Timeline
- Start
- 2019-05-28
- Primary completion
- 2022-05-20
- Completion
- 2024-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neoadjuvant chemotherapy with PSOX regimen. | Unknown | 40 mg/m2 | — |
| Subject | Neoadjuvant chemotherapy with PSOX regimen. | Unknown | 60 mg/m2 | — |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 135 mg/m2 | — |